Buserelin Acetate

醋酸布舍瑞林

Report date: 2023/01/13 20:00:32
NME

Base Information

Drug NameBuserelin Acetate
Drug Alias Name布赛来灵醋酸酯buserelinabuserelinumProfactSuprefact +[7] 
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionGonadotropin-releasing hormone receptor agonists
TargetsGonadotropin-releasing hormone receptor
Therapy Area/IndicationsPuberty, PrecociousEndometriosisProstatic Neoplasms +[5] 
Global Approved IndicationsEndometriosis
Approved Indications in ChinaN/A
Original Approved Country/TerritoryJapan
Original Approved DateN/A
Country/TerritoryEUJapan
CombinationsNo
Global Highest StatusApproved
Highest Status in ChinaN/A
Originator CompaniesN/A
China Registration ClassN/A

Develop Information

Active CompaniesClinigen Inc
Inactive CompaniesN/A
Active IndicationsPuberty, PrecociousEndometriosisProstatic Neoplasms +[5] 
Inactive IndicationsN/A

Other Information

ATC CodeL02AE01
Related LinksWikipediaDrugBankKEGG